Nov 09, 2023 / 03:00PM GMT
Operator
Good morning, and welcome to the AC Immune KOL webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the AC Immune website following the conclusion of the event.
I'd now like to turn the call over to Gary Waanders, Head of Investor Relations and Communications at AC Immune. Please go ahead, Gary.
Gary Waanders - AC Immune SA - Head of IR & Corporate Communications
Thanks, Tara. It's a pleasure to welcome you all to our webinar today on the topic of Abeta PET imaging and its importance as a surrogate marker of clinical efficacy. Before we begin, I'd like to draw your attention to our disclaimer about our forward-looking statements.
And so today, we'll be hearing from our CEO at AC Immune, Andrea Pfeifer, to present an overview of the company's strategy and pipeline, with a focus on our active immunotherapy platform, particularly as it relates to our anti-Abeta candidate, ACI-24.060. Then we will hear from Professor Victor Villemagne of the University of Pittsburgh, an
AC Immune SA KOL Webinar Transcript
Nov 09, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers